- News & Analysis
Page 582
AzBio helps seed $200m fund
Trade body AzBio has joined two non-profit organisations to launch the AZ-HCIF commercialisation fund for life science discoveries.
Jan 17, 2018Aprinoia traces corporates for series B round
The neurogenerative disease diagnostics technology developer has secured $11.1m in a ShangPharma and TaiAn Technologies-backed round.
Jan 16, 2018Vaccitech gets GV-backed funding injection
The corporate venturing unit co-led the vaccine developer's $27.1m series A round with Oxford Sciences Innovation and Sequoia Capital China.
Jan 15, 2018MetLife unleashes $100m co-investment arm
The insurance group launched strategic investment vehicle MetLife Digital Ventures alongside an accelerator partnership with Techstars.
Jan 15, 2018Zelgen sells Minsheng on $62m series B
Minsheng Life Insurance has co-led a series B round for Suzhou Zelgen, which is developing drugs for diseases including cancer.
Jan 15, 2018NanoCellect categorises Highlander commitment
The cell sorting technology developer has become the first company to be backed by the University of California Riverside-focused VC vehicle Highlander Venture Fund.
Jan 15, 2018Celgene provides Sanofi with $1.1bn Impact exit
Sanofi will exit cancer drug developer Impact Biomedicines in an acquistion by Celgene that consists of $1.1bn up front and potentially billions in milestone payments.
Jan 12, 2018About us
GCV provides the global corporate venturing community and their ecosystem partners with the information, insights and access needed to drive impactful open innovation. Across our three services - News & Analysis, Community & Events, and the GCV Institute - we create a network-rich environment for global innovation and capital to meet and thrive. At the heart of our community sits our membership, providing privileged access to all our services and resources.
Navigation
© 2026 Mawsonia Ltd. All rights reserved.test regLogin